Beena Thannickal

Beena Thannickal

| This email address is being protected from spambots. You need JavaScript enabled to view it.
(205) 975-3967

Cancer research and patient care
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
UAB is the first in the country to use novel HyperArc High-Definition Radiotherapy on brain cancer patients.
UAB Hospital has received a 2017 Women’s Choice Award for being one of America’s Best Breast Centers in the United States.
Several activities are planned in and around UAB for Breast Cancer Awareness Month.
An art event will be held Aug. 17 to engage the cancer community in the healing power of art.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
Recent findings from an innovative nationwide trial indicate that the drug pembrolizumab, when used in combination with standard therapy, may provide positive results for patients with locally advanced breast cancer.
The new UAB Breast Cancer Survivorship Clinic provides breast cancer patients extended follow-up care, helping them adjust to physical and emotional changes after treatment.
The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
The annual symposium May 15 will provide help and support for cancer patients and survivors.
Page 1 of 22
Back to Top